We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

84 hedge funds and large institutions have $200M invested in Minerva Neurosciences in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

2% more funds holding

Funds holding: 82 → 84 (+2)

0.14% more ownership

Funds ownership: 9.42% → 9.56% (+0.14%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

45% less capital invested

Capital invested by funds: $367M → $200M (-$166M)

Holders
84
Holders Change
+2
Holders Change %
+2.44%
% of All Funds
1.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
31
Reduced
25
Closed
6
Calls
$258K
Puts
–
Net Calls
+$258K
Net Calls Change
-$77K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.49M
2
NLVP
New Leaf Venture Partners
New York
+$2.68M
3
AL
AJO LP
Pennsylvania
+$1.41M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.36M
5
Morgan Stanley
Morgan Stanley
New York
+$866K

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$3.07M
2
HCMT
Highland Capital Management (Texas)
Texas
-$2.58M
3
NC
Northpointe Capital
Michigan
-$1.76M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.36M
5
JG
Jefferies Group
New York
-$952K
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$931K +$163K +2,232 +15%
OAM
27
Oxford Asset Management
United Kingdom
$906K +$549K +7,500 +81%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$900K +$62.1K +848 +5%
Goldman Sachs
29
Goldman Sachs
New York
$777K +$109K +1,485 +11%
Squarepoint
30
Squarepoint
New York
$666K +$351K +4,797 +63%
Citadel Advisors
31
Citadel Advisors
Florida
$625K +$109K +1,495 +15%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$614K +$313K +4,282 +60%
NC
33
Northpointe Capital
Michigan
$607K -$1.76M -24,070 -68%
AA
34
ALPS Advisors
Colorado
$605K +$194K +2,651 +31%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$569K -$54.9K -750 -7%
GCP
36
GSA Capital Partners
United Kingdom
$522K +$102K +1,400 +17%
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$514K +$306K +4,174 +78%
BCM
38
Bridgeway Capital Management
Texas
$502K -$189K -2,587 -22%
TA
39
Teachers Advisors
New York
$464K +$79.7K +1,089 +14%
Charles Schwab
40
Charles Schwab
California
$442K – – –
AWCI
41
Alpine Woods Capital Investors
New York
$407K -$9.15K -125 -2%
Swiss National Bank
42
Swiss National Bank
Switzerland
$387K – – –
Wells Fargo
43
Wells Fargo
California
$354K +$350K +4,780 +268%
Deutsche Bank
44
Deutsche Bank
Germany
$349K -$212K -2,901 -31%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$348K +$13.7K +187 +3%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$324K +$7.91K +108 +2%
Two Sigma Investments
47
Two Sigma Investments
New York
$317K +$205K +2,797 +91%
AllianceBernstein
48
AllianceBernstein
Tennessee
$311K – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$276K +$122K +1,667 +48%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$216K +$128K +1,750 +78%
1
2
3 4

NERV Hedge Fund Activity: Q4 2018 in Review

84 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2018, worth a combined $200M — down 45% from $367M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NERV positions and 6 closed out — a net gain of 2 holders — while 31 added to existing stakes and 25 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $4.49M. The largest seller was Marshall Wace North America, cutting an estimated $3.07M.

  • 84 institutional investors held Minerva Neurosciences (NERV) as of Q4 2018, up from 82 in Q3 2018.
  • Funds reported $200M of Minerva Neurosciences stock for Q4 2018, down 45% quarter-over-quarter.
  • 8 funds opened new Minerva Neurosciences positions in Q4 2018 and 6 closed out, a net change of +2 holders.
  • The largest Minerva Neurosciences buyer in Q4 2018 was Wellington Management Group, an estimated $4.49M added.
  • The largest Minerva Neurosciences seller in Q4 2018 was Marshall Wace North America, an estimated $3.07M sold.

Based on aggregated 13F filings for Q4 2018.